27
Jun
New Delhi: The government on Saturday allowed the use of the low-cost steroid drug dexamethasone as an alternative to methylprednisolone to treat coronavirus patients with moderate and severe symptoms. The World Health Organization had called for a rapid increase in production of dexamethasone, after British clinical trials found it had life-saving potential for critically-ill coronavirus patients. The Union Health Ministry has put a revised version of "Clinical Management Protocol: COVID-19" - a document published for use by health professionals as a reference . Earlier this month, the ministry had added the loss of smell and taste as new symptoms of COVID-19…
